-
1.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 细胞凋亡诱导剂治疗癌症和免疫及自身免疫疾病公开(公告)号:WO2010138588A3
公开(公告)日:2011-04-07
申请号:PCT/US2010036198
申请日:2010-05-26
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
IPC: C07D471/04 , A61K31/437 , A61P35/00
CPC classification number: C07D471/04 , C07D491/052 , C07D519/00
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有该化合物的组合物和治疗表达抗凋亡Bcl-2蛋白的疾病的方法。
-
2.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 用于治疗癌症和免疫和自发性疾病的病毒诱导剂公开(公告)号:WO2010138588A9
公开(公告)日:2011-05-05
申请号:PCT/US2010036198
申请日:2010-05-26
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
IPC: C07D471/04 , A61K31/437 , A61P35/00
CPC classification number: C07D471/04 , C07D491/052 , C07D519/00
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有化合物的组合物和治疗疾病的方法,其中表达抗凋亡Bcl-2蛋白。
-
3.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 用于治疗癌症和免疫和自发性疾病的病毒诱导剂公开(公告)号:WO2010083441A3
公开(公告)日:2010-09-10
申请号:PCT/US2010021243
申请日:2010-01-15
Applicant: ABBOTT LAB , HEXAMER LAURA , DING HONG , ELMORE STEVEN W , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WENDT MICHAEL D
Inventor: HEXAMER LAURA , DING HONG , ELMORE STEVEN W , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WENDT MICHAEL D
IPC: C07D209/08 , A61K31/635 , A61P35/00 , C07D213/71 , C07D231/56 , C07D235/04 , C07D265/02 , C07D285/14 , C07D295/155 , C07D311/14
CPC classification number: C07D295/155 , C07D209/08 , C07D213/71 , C07D231/56 , C07D235/04 , C07D265/02 , C07D285/14 , C07D311/14
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的式(I)化合物,含有该化合物的组合物和治疗其中表达抗凋亡Bcl-2蛋白的疾病的方法。
-
4.
公开(公告)号:WO2010065824A3
公开(公告)日:2010-10-07
申请号:PCT/US2009066722
申请日:2009-12-04
Applicant: ABBOTT LAB , BRUNCKO MILAN , DAI YUJIA , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
Inventor: BRUNCKO MILAN , DAI YUJIA , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: A61P35/00 , A61K31/496 , C07D403/12
CPC classification number: C07D405/12 , C07D209/08 , C07D211/58 , C07D213/74 , C07D213/84 , C07D231/56 , C07D235/06 , C07D277/24 , C07D295/30 , C07D309/04 , C07D401/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D471/04
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
-
5.INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME 审中-公开
Title translation: 二乙酰胆碱酯酶1型酶的抑制剂公开(公告)号:WO2007137107A3
公开(公告)日:2008-01-10
申请号:PCT/US2007069112
申请日:2007-05-17
Applicant: ABBOTT LAB , IYENGAR RAJESH R , ZHAO GANG , FREEMAN JENNIFER C , GAO JU , JUDD ANDREW S , KYM PHILIP R , LYNCH JOHN K , MULHERN MATHEW M , SOUERS ANDREW J
Inventor: IYENGAR RAJESH R , ZHAO GANG , FREEMAN JENNIFER C , GAO JU , JUDD ANDREW S , KYM PHILIP R , LYNCH JOHN K , MULHERN MATHEW M , SOUERS ANDREW J
IPC: C07C211/22 , A61K31/155 , A61K31/17 , A61K31/381 , A61K31/4164 , A61K31/435 , A61P3/04 , C07C275/30 , C07C279/18 , C07C335/16 , C07D213/55 , C07D213/75 , C07D277/28 , C07D333/36
CPC classification number: C07C335/22 , C07C229/46 , C07C275/30 , C07C275/32 , C07C275/38 , C07C279/28 , C07C2601/08 , C07C2601/14 , C07D213/55 , C07D213/75 , C07D277/30 , C07D333/22 , C07D333/36 , C07D401/04 , C07D401/12 , C07D409/12 , C07D409/14
Abstract: The present invention relates to compounds of formula (I) wherein R 1 , R 3 , X, Q, Z, A, D, m, and n are defined herein. Pharmaceutical compositions and methods for treating DGAT-1 related diseases or conditions are also disclosed.
Abstract translation: 本发明涉及式(I)化合物,其中R 1,R 3,X,Q,Z,A,D,m和n如本文所定义。 还公开了治疗DGAT-1相关疾病或病症的药物组合物和方法。
-
6.APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES 审中-公开
Title translation: 用于治疗癌症和免疫和自发性疾病的病毒诱导剂公开(公告)号:WO2011119345A2
公开(公告)日:2011-09-29
申请号:PCT/US2011027895
申请日:2011-03-10
Applicant: ABBOTT LAB , DING HONG , ELMORE STEVEN , HEXAMER LAURA , KUNZER AARON R , PARK CHEOL-MIN , SOUERS ANDREW J , SULLIVAN GERARD , WENDT MICHAEL
Inventor: DING HONG , ELMORE STEVEN , HEXAMER LAURA , KUNZER AARON R , PARK CHEOL-MIN , SOUERS ANDREW J , SULLIVAN GERARD , WENDT MICHAEL
IPC: C07D295/195 , A61K31/18 , A61K31/451 , A61K31/495 , A61P35/00 , C07C311/51 , C07D211/58
CPC classification number: C07D211/58 , C07C311/51 , C07C2601/14 , C07C2603/74 , C07D295/112 , C07D295/195 , C07D417/04
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti apoptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡Bcl-2蛋白活性的化合物,含有这些化合物的组合物和治疗其中表达抗凋亡Bcl-2蛋白的疾病的方法。
-
7.SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES 审中-公开
Title translation: 作为治疗癌症和免疫疾病的BCL-2-选择性病毒诱导剂的磺酰胺衍生物公开(公告)号:WO2010065865A3
公开(公告)日:2010-09-16
申请号:PCT/US2009066790
申请日:2009-12-04
Applicant: ABBOTT LAB , BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12
CPC classification number: C07D405/12 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D231/56 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12 , C07D417/12
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BcI -2 or BcI -xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti -aooptotic Bcl-2 protein.
Abstract translation: 公开了抑制抗凋亡BcI -2或BcI-xL蛋白活性的式(I)化合物,含有该化合物的组合物和治疗其中表达抗细胞凋亡Bcl-2蛋白的疾病的方法。
-
公开(公告)号:WO2008131000A3
公开(公告)日:2008-12-18
申请号:PCT/US2008060472
申请日:2008-04-16
Applicant: ABBOTT LAB , ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , HASVOLD LISA A , WANG LE , KUNZER AARON R , PARK CHEOL-MIN , WENDT MICHAEL D , TAO ZHI-FU
Inventor: ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , HASVOLD LISA A , WANG LE , KUNZER AARON R , PARK CHEOL-MIN , WENDT MICHAEL D , TAO ZHI-FU
IPC: C07D209/34 , A61K31/404 , A61P35/00 , C07D401/12 , C07D413/06 , C07D417/04
CPC classification number: C07D209/42 , A61K31/5377 , C07D209/34 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D491/113
Abstract: Compounds of formula (I) which inhibit the activity of anti-apoptotic McI-I protein, compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated McI-I protein are disclosed.
Abstract translation: 公开了抑制抗凋亡McI-1蛋白活性的式(I)化合物,含有该化合物的组合物,以及治疗涉及过表达或未调节的McI-1蛋白的疾病的方法。
-
公开(公告)号:EP2376085A4
公开(公告)日:2012-08-15
申请号:EP09837907
申请日:2009-12-17
Applicant: GENENTECH INC , INST MEDICAL W & E HALL , ABBOTT LAB
Inventor: BAELL JONATHAN BAYLDON , BUI CHINH THIEN , COLMAN PETER , DUDLEY DANETTE A , FAIRBROTHER WAYNE J , FLYGARE JOHN A , LESSENE GUILLAUME LAURENT , NDUBAKU CHUDI , NIKOLAKOPOULOS GEORGE , RYE CARL STEVEN , SLEEBS BRAD EDMUND , SMITH BRIAN JOHN , WATSON KEITH GEOFFREY , ELMORE STEVEN W , PETROS ANDREW M , SOUERS ANDREW J , CZABOTAR PETER
IPC: A61K31/535 , C07D417/14 , C07D487/04
CPC classification number: C07D417/14 , C07D417/12 , C07D487/04
-
10.INHIBITORS OF DIACYLGLYCEROL O-ACYLTRANSFERASE TYPE 1 ENZYME 有权
Title translation: 抑制剂二酰基甘油O-酰基转移酶1型酶公开(公告)号:EP2117526A4
公开(公告)日:2011-07-27
申请号:EP07854765
申请日:2007-11-26
Applicant: ABBOTT LAB
Inventor: SOUERS ANDREW J , GAO JU , HANSEN TODD MATTHEW , IYENGAR RAJESH R , KYM PHILIP R , LIU BO X , PEI ZHONGHUA , YEH VINCE , ZHAO GANG , XIN ZHILI
IPC: A61K31/17 , A61P1/16 , A61P3/00 , C07C229/40 , C07D231/20 , C07D263/48 , C07D277/38 , C07D403/04 , C07D405/04 , C07D487/04
CPC classification number: C07D487/04 , C07C59/54 , C07C275/42 , C07D211/60 , C07D231/12 , C07D231/20 , C07D249/08 , C07D263/48 , C07D277/40 , C07D401/04 , C07D407/12 , C07D407/14 , C07D413/12 , C07D413/14
-
-
-
-
-
-
-
-
-